CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 9 of 11

Lupus Science & Medicine

Briefs 321–360 of 423 CurrentRheuma has covered from this journal, newest publication first

Latest from Lupus Science & Medicine

All coverage, newest first

  1. Lupus Sci Med

    Outcome clusters and their stability over 1 year in patients with SLE: self-reported and performance-based cognitive function, disease activity, mood and health-related quality of life

    Cohort studyLupus & APS

  2. Lupus Sci Med

    Real-world effectiveness of belimumab in patients with lupus in China: RELIABLE observational cohort study protocol

    Trial designLupus & APS

  3. Lupus Sci Med

    Antiplatelet effects of hydroxychloroquine in patients with systemic lupus erythematosus evaluated by the total thrombus-formation analysis system (T-TAS)

    Cross-sectional studyLupus & APS

  4. Lupus Sci Med

    Intercurrent infection as a risk factor for disease flares in patients with systemic lupus erythematosus

    Cohort studyLupus & APS

  5. Lupus Sci Med

    Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study

    Cohort studyLupus & APS

  6. Lupus Sci Med

    Multidisciplinary re-evaluation of neuropsychiatric events to confirm the neuropsychiatric lupus diagnosis at an Indonesian tertiary hospital

    Cross-sectional studyLupus & APS

  7. Lupus Sci Med

    Combination of anti-SSA/Ro60 and anti-dsDNA serotype is predictive of belimumab renal response in patients with lupus nephritis

    Cohort studyLupus & APS

  8. Lupus Sci Med

    Prevalence of major adverse cardiovascular events among Saudi patients with systemic lupus erythematosus compared with the general population: updates from the national SLE and PURE cohorts

    Cohort studyLupus & APS

  9. Lupus Sci Med

    iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus

    Diagnostic or prognostic studyLupus & APS

  10. Lupus Sci Med

    Development and validation of a risk scoring system to identify patients with lupus nephritis in electronic health record data

    Diagnostic or prognostic studyLupus & APS

  11. Lupus Sci Med

    Positive psychosocial factors may protect against perceived stress in people with systemic lupus erythematosus with and without trauma history

    Cross-sectional studyLupus & APS

  12. Lupus Sci Med

    Epidemiology of SLE in Italy: an observational study using a primary care database

    Cohort studyLupus & APS

  13. Lupus Sci Med

    Multiple polygenic risk scores can improve the prediction of systemic lupus erythematosus in Taiwan

    Case-control studyLupus & APS

  14. Lupus Sci Med

    Frequency of sarcopenia in Turkish women with systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  15. Lupus Sci Med

    SF-36v2 and FACIT-Fatigue quality of life improvements with organ-specific SELENA-SLEDAI response and belimumab treatment in patients with systemic lupus erythematosus

    Meta-analysisLupus & APS

  16. Lupus Sci Med

    Higher mortality risk from gynaecological neoplasms and non-Hodgkin’s lymphoma in patients with systemic lupus erythematosus: an observational study from the Spanish National Registry

    Cohort studyLupus & APS

  17. Lupus Sci Med

    Comparison of cognitive performance measures in individuals with systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  18. Lupus Sci Med

    Novel potential lncRNA biomarker in B cells indicates essential pathogenic pathway activation in patients with SLE

    Mechanistic studyLupus & APS

  19. Lupus Sci Med

    Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus

    Cohort studyLupus & APS

  20. Lupus Sci Med

    Exacerbating effects of circadian rhythm disruption on the systemic lupus erythematosus

    Cohort studyLupus & APS

  21. Lupus Sci Med

    SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Diagnostic or prognostic studyLupus & APS

  22. Lupus Sci Med

    Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count

    Cohort studyLupus & APS

  23. Lupus Sci Med

    Association of phenotypic frailty and hand grip strength with telomere length in SLE

    Cross-sectional studyLupus & APS

  24. Lupus Sci Med

    Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: a systematic review and meta-analysis

    Meta-analysisLupus & APS

  25. Lupus Sci Med

    Enhanced medullary and extramedullary granulopoiesis sustain the inflammatory response in lupus nephritis

    Mechanistic studyLupus & APS

  26. Lupus Sci Med

    Association of genetic variation on X chromosome with systemic lupus erythematosus in both Thai and Chinese populations

    Meta-analysisLupus & APS

  27. Lupus Sci Med

    Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease

    Randomized controlled trialLupus & APS

  28. Lupus Sci Med

    Differences in reproductive health discussions in an urban Hispanic population with SLE: lessons from the field

    Cross-sectional studyLupus & APS

  29. Lupus Sci Med

    Potential involvement of circulating exosomal miRNA-146a in disease activity and TRAF6 gene expression in juvenile proliferative lupus nephritis

    Cohort studyPediatric

  30. Lupus Sci Med

    Add-on sirolimus for the treatment of mild or moderate systemic lupus erythematosus via T lymphocyte subsets balance

    Cohort studyLupus & APS

  31. Lupus Sci Med

    Prevalence of coeliac disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis

    Meta-analysisLupus & APS

  32. Lupus Sci Med

    Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132

    Randomized controlled trialLupus & APS

  33. Lupus Sci Med

    Novel multiclass classification machine learning approach for the early-stage classification of systemic autoimmune rheumatic diseases

    Diagnostic or prognostic studyAcross diseases

  34. Lupus Sci Med

    Large overlap in neutrophil transcriptome between lupus and COVID-19 with limited lupus-specific gene expression

    Mechanistic studyLupus & APS

  35. Lupus Sci Med

    High-density lipoprotein cholesterol subfraction HDL2 is associated with improved endothelial function in systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  36. Lupus Sci Med

    Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus

    Cohort studyPediatric

  37. Lupus Sci Med

    Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis

    Meta-analysisLupus & APS

  38. Lupus Sci Med

    Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies

    Meta-analysisLupus & APS

  39. Lupus Sci Med

    Joint surgery rates in lupus: a long-term cohort study

    Cohort studyLupus & APS

  40. Lupus Sci Med

    Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritis

    Cohort studyLupus & APS

All 423 Briefs in ExploreShowing Briefs 321–360 of 423, newest first